Tenaya Therapeutics (TNYA) Receivables - Other (2022)
Tenaya Therapeutics (TNYA) posted quarterly Receivables - Other of $2.0 million for Q4 2022, little changed quarter-over-quarter from $2.0 million in Q2 2022.
Tenaya Therapeutics (TNYA) Receivables - Other (2022) Analysis & Trends
Tenaya Therapeutics' Receivables - Other history runs 1 years deep, the most recent figure standing at $2.0 million for Q4 2022.
- In Q4 2022, Receivables - Other changed N/A year-over-year to $2.0 million; the TTM figure through Dec 2022 stood at $2.0 million (changed N/A YoY), while the FY2022 annual figure was $2.0 million, changed N/A from the prior year.
- Receivables - Other for Q4 2022 stood at $2.0 million, roughly flat from $2.0 million in the prior quarter.
- The five-year high for Receivables - Other was $2.0 million in Q2 2022, with the low at $2.0 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tenaya Therapeutics | 151.50 Mn | 151.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2.00 Mn |
| Dec 31, 2022 | 2.00 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 2.00 Mn |